Neuronetics Inc (STIM)

Currency in USD
3.330
-0.110(-3.20%)
Closed·
3.3300.000(0.00%)
·
STIM Scorecard
Full Analysis
Analysts anticipate sales growth in the current year
STIM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3.1803.480
52 wk Range
0.5205.920
Key Statistics
Prev. Close
3.44
Open
3.46
Day's Range
3.18-3.48
52 wk Range
0.52-5.92
Volume
1.47M
Average Volume (3m)
1.11M
1-Year Change
277.08%
Book Value / Share
0.41
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
STIM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.500
Upside
+95.20%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Neuronetics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Neuronetics Inc Company Profile

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Neuronetics Inc SWOT Analysis


Merger Momentum
Neuronetics' merger with Greenbrook TMS shows early success, with significant synergies realized and expanded market presence driving growth potential
Financial Resilience
Despite high Q1 cash burn, Neuronetics projects cash flow breakeven by Q3 2025 and maintains a healthy current ratio of 2.44
Strategic Expansion
SPRAVATO rollout and Brain Music Programming initiatives poised to boost revenue, with potential for adolescent indication coverage opening new markets
Market Outlook
Analysts set $7.00 price target, reflecting optimism in Neuronetics' growth trajectory amid competitive neurohealth solutions landscape
Read full SWOT analysis

Neuronetics Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of -$0.15 missed forecast of -$0.08; revenue beat at $38.1M vs $36.59M expected
  • Stock fell 12.77% to $4.15 pre-market; gross margin decreased to 46.6% from 74% YoY
  • Company targets cash flow positivity by Q4 2025; projects FY revenue of $149M-$155M
  • Integration with Greenbrook progressing as anticipated, according to CEO Keith Sullivan
  • Q3 guidance: revenue $37M-$39M, gross margin 48-50%, cash flow -$3M to breakeven
Last Updated: 05/08/2025, 16:40
Read Full Transcript

Compare STIM to Peers and Sector

Metrics to compare
STIM
Peers
Sector
Relationship
P/E Ratio
−4.5x−3.9x−0.5x
PEG Ratio
−0.48−0.100.00
Price/Book
8.1x3.9x2.6x
Price / LTM Sales
2.0x3.8x3.2x
Upside (Analyst Target)
110.2%26.1%38.8%
Fair Value Upside
Unlock−2.3%5.4%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.500
(+95.20% Upside)

Earnings

Latest Release
Aug 05, 2025
EPS / Forecast
-0.15 / -0.08
Revenue / Forecast
38.11M / 36.59M
EPS Revisions
Last 90 days

STIM Income Statement

People Also Watch

182.20
ALAB
-3.67%
4.580
ATAI
-1.51%
4.510
PGEN
-0.88%
9.600
UMAC
-5.60%
5.860
ONDS
+2.81%

FAQ

What Stock Exchange Does Neuronetics Trade On?

Neuronetics is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Neuronetics?

The stock symbol for Neuronetics is "STIM."

What Is the Neuronetics Market Cap?

As of today, Neuronetics market cap is 220.20M.

What Is Neuronetics's Earnings Per Share (TTM)?

The Neuronetics EPS (TTM) is -1.00.

When Is the Next Neuronetics Earnings Date?

Neuronetics will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is STIM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Neuronetics Stock Split?

Neuronetics has split 0 times.

How Many Employees Does Neuronetics Have?

Neuronetics has 716 employees.

What is the current trading status of Neuronetics (STIM)?

As of 31 Aug 2025, Neuronetics (STIM) is trading at a price of 3.330, with a previous close of 3.44. The stock has fluctuated within a day range of 3.180 to 3.480, while its 52-week range spans from 0.520 to 5.920.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.